 Bright alleges that he was retaliated against after raising concerns about the federal government’s lack of medical protective equipment, and its apparent unwillingness to take urgent action to adequately prepare for the coronavirus pandemic.Additionally, Dr.Bright was reluctant to push unproven, and potentially dangerous drugs – specifically, the antimalarial drug hydroxychloroquine – through approval processes, despite pressure from his superiors who Dr.